More
    Guided Solutions - Connecting Talent With Innovation/div>

    Fractyl reports positive 2-year Revita results, prices $20m offering

    Fractyl Health announced new data supporting its Revita procedure and priced a new public offering. The data came from the company’s Germany Real-world Registry. It showed that a single Revita procedure led to durable weight...

    Fractyl reports positive 2-year Revita results, prices $20m offering

    Fractyl Health announced new data supporting its Revita procedure and priced a new public offering. The data came from the company’s Germany Real-world Registry. It...

    Cornerstone Robotics advances endoscopic surgical robot platform

    Cornerstone Robotics and researchers at the Chinese University of Hong Kong (CUHK) say they made a breakthrough in surgical robotics. According to a news release,...

    Alcon strikes $1.5bn deal to acquire ailing rival STAAR Surgical

    Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn. The deal equates to the buyout...

    Pulsecare gets regulatory nod for nanosecond PFA in China

    Pulsecare Medical announced that Chinese regulatory authorities granted marketing approval for its pulsed field ablation technology. Shenzhen, China–based Pulsecare develops the NxPFA nanosecond PFA system....
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Fractyl reports positive 2-year Revita results, prices $20m offering

    Fractyl Health announced new data supporting its Revita procedure and priced a new public offering. The data came from the company’s Germany Real-world Registry. It...

    InterVene’s thrombectomy catheter showed success in first-in-human case

    The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents. The...

    Xvivo enrolls first patient in Heart Assist Transport device study

    Xvivo announced it enrolled the first patient as part of a continued access protocol (CAP) study for its Heart Assist Transport system. The CAP study...

    Xeltis reports positive EU trial results for Xabg coronary bypass conduit

    Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces encouraging preliminary data for Xabg,...

    Innovation

    Regulatory Approvals

    Fractyl reports positive 2-year Revita results, prices $20m offering

    Fractyl Health announced new data supporting its Revita procedure and priced a new public offering. The data came from the company’s Germany Real-world Registry. It...

    Cornerstone Robotics advances endoscopic surgical robot platform

    Cornerstone Robotics and researchers at the Chinese University of Hong Kong (CUHK) say they made a breakthrough in surgical robotics. According to a news release,...

    Alcon strikes $1.5bn deal to acquire ailing rival STAAR Surgical

    Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn. The deal equates to the buyout...

    Pulsecare gets regulatory nod for nanosecond PFA in China

    Pulsecare Medical announced that Chinese regulatory authorities granted marketing approval for its pulsed field ablation technology. Shenzhen, China–based Pulsecare develops the NxPFA nanosecond PFA system....

    M&A

    Archives

    Latest articles